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Our previous studies have shown that one manganous ion binds tightly to bovine brain hexokinase, with a 
Kd =25 _+ 4 pM. The characteristic proton relaxation rate (PRR) enhancement of this binary complex ( E ~ )  is 3.5 at 
9 MHz and 23 "C [ Jarori, G. K. Kasturi, S. R., and Kenkare, U. W. (1981) Arch. Biochem. Biophys. 211,258 - 2681. 
On the basis of PRR enhancement patterns, observed on the addition of nucleotides ATP and ADP to this E . Mn 
binary complex, we now show the formation of a nucleotide-bridge ternary complex, enzyme . nucleotide . Mn. 
Addition of glucose 6-phosphate to enzyme . ATP . Mn, results in a competitive displacement of ATP Mn from the 
enzyme. However, a quaternary complex E . ADP . Mn . Glc-6-P appears to be formed when both the products are 
present. 
p, y-Bidentate Cr(II1)ATP has been used to elucidate the role of direct binding of Mn(I1) in catalysis, and the 
stoichiometry of metal-ion interaction with the enzyme in the presence of nucleotide. Bidentate Cr(II1)ATP serves as 
a substrate for brain hexokinase without any additional requirement for a divalent cation. However, electron-spin 
resonance studies on the binding of Mn(I1) to the enzyme in the presence of Cr(I1I)ATP suggest that, in the presence 
of nucleotide, two metal ions interact with hexokinase, one binding directly to the enzyme and the second interacting 
via the nucleotide bridge. It is this latter one which participates in catalysis. 
Experiments carried out with hexokinase spin-labeled with 3-(2-iodo-acetamido)-2,2,5,5-tetramethyl-l- 
pyrrolidinyloxyl clearly showed that the direct-binding Mn site on the enzyme is distinctly located from its ATP Mn 
binding site. 
Bovine brain hexokinase catalyzes the transfer of the y-  
phosphoryl group of ATP to the sixth hydroxyl group of 
glucose, resulting in the formation of Glc-6-P and ADP. The 
enzyme shows an absolute requirement for a divalent cation, 
which is Mg(I1) in vivo [l]. Our earlier studies have shown that 
Mg(I1) can be replaced by Mn(I1) and that the enzyme has one 
tight binding site for Mn(I1) [2]. Kinetic studies have shown 
that MgATP2- is the true substrate for hexokinase [3]. 
However, the mode of co-ordination of metal-ion . nucleotide 
comvlex with brain hexokinase is not understood. The first 
ganous chloride (0.1 M) solution was supplied by Sigma 
Chemical Company (St. Louis, Missouri). Bovine serum 
albumin was obtained from Nutritional Biochemicals Cor- 
poration (USA). Dowex-50x -2H+ was from Bio-Rad 
(USA). [U-'4C]Glucose was supplied by Bhabha Atomic 
Research Centre (Bombay, India). The spin label 3-(2- 
iodoacetamido)-2,2,5,5-tetramethyl- 1 -pyrrolidinyloxyl was ob- 
tained from Syva Research Chemicals (California, USA). 
Preoarution o f  hexokinuse 
objective of our study was to investigate the nature of enzyme, 
nucleotide and metal ion co-cordination using a proton 
relaxation enhancement (PRE) method [4,5]. Since ATP itself 
has a high affinity for divalent cations and since hexokinase 
objective of our study was to investigate the possible existence 
of a quaternary Mn . E . ATP . Mn complex using principally 
magnetic resonance methods. 
Type I hexokinase was purified to apparent homogeneity 
from bovine brain mitochondria as described by Redkar and 
Kenkare [61 with one modification, EDTA was eliminated in 
the second DEAE-cellulose chromatography, Protein con- 
method of Lowry et al. [7] using crystalline bovine serum 
albumin as standard. For all magnetic resonance experiments, 
samples were prepared as described earlier [2]. The enzyme used 
forms a tight E ' M n  binary [ 2 1 3  the second centration in purified preparations was determined by the 
MATERIALS AND METHODS 
Chemicals 
in these experiments was at least 95 "/, pure and had a specific 
activity of approximately 60 units mg protein. 
Kinetic studies 
NADP7 G1c-6-P and G1c-6-P dehydrogenase 
were obtained from Boehringer-Mannheim (FRG). Man- 
Abbreviations. PRR, proton relaxation rate; Glc-6-P, glucose 6- 
phosphate. 
Enzymes, Hexokinase (EC 2.7.1.1); creatine kinase (EC 2.7.3.2) 
phosphofructokinase (EC 2.7.1.11); arginine kinase (EC 2.7.3.3); 
glucose-6-phosphate dehydrogenase (EC 1.1.1.49). mixture. 
Hexokinase was assayed spectrophotometrically by the 
method described earlier [6]. In the experiments where 
Cr(II1)ATP was used as an inhibitor versus MgATP, the 
reaction was started by the addition of hexokinase and was 
monitored for 1 -2 min Only. This Precaution was taken to 
avoid hydrolysis of Cr(1II)ATP at the pH 8.0 of the assay 
- 
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The substrate activity of p, y-bidentate Cr(1II)ATP for 
brain hexokinase was monitored using Dowex-50 assay[8]. 
Reaction mixture, containing [U-'4C]glucose, Cr(II1)ATP 
and enzyme, was incubated for 10min. The reaction was 
terminated by the addition of 20 pl perchloric acid and 2 drops 
of CCI4 to the vortexing mixture. The solution was then diluted 
to 1.0 ml and centrifuged (10000 xg).  The supernatant was 
adsorbed on a 25 x 0.5-cm column of Dowex-50 x -2H' at 
4 "C. Thecolumn was washed with 75 ml10 m M  HCI followed 
by 75 ml 1 M HCI. The 5.0-ml fractions were assayed for 14C 
and the relative amounts of unreacted substrate and product 
were determined. 
Preparation of [j, y-bidentate Cr(IIi) ATP 
j, y-Bidentate Cr(I1I)ATP was prepared by the pH titra- 
tion at 4 "C of a mixture of Na,H,ATP and CrCI, up to pH 5.7. 
The solution was then allowed to warm to room temperature 
for 30 min. p, y-bidentate Cr(II1)ATP was then purified by 
adsorption on a Dowex-50x -2H+ column followed by 
elution with aniline. The aniline was removed by extraction 
with ether. The solution was stored at  -20°C [9]. This 
preparation did not have any free ATP. However, the presence 
of small amounts of tridentate Cr(II1)ATP cannot be ruled 
out. 
Magnetic resonance measurements 
Spin-lattice relaxation times (TI) of solvent water pro- 
tons were measured at  9 MHz using a Spin-Lock model 
CPS-2 spectrometer (Spin-Lock Ltd, Port Credit, Ontario, 
Canada) and a box-car averager (Princeton Applied Re- 
search Corporation, model 162), using the methods described 
earlier [2]. 
In Mn(I1) binding assays the concentrations of free 
Mn(I1) were monitored using an  X-band (9.5 GHz) Varian 
E-line ESR spectrometer located at the Regional Sophisti- 
cated Instrumentation Centre (Powai, Bombay). 20 -25 p1 
samples were placed in constant-diameter glass capillaries for 
recording the ESR spectrum of free Mn(1I). Amplitudes of the 
first low-field line were used to measure the amount of free 
Mn(I1) [lo]. 
Analysis of' N M R  data 
The enhancement factor E* is defined in the usual way as 
the ratio of the paramagnetic contributions to the relaxation 
rate in the presence and the absence of the macromolecule, i.e. 
where asterisks indicate the presence of macromolecule and 
the l/TL(o, is the relaxation rate in the absence of the 
paramagnetic ion. 
Spin labeling 
The spin label used was 3-(2-iodoacetamido)-2,2,5,5- 
tetramethyl-1-pyrrolidinyloxyl. For spin labeling, hexokinase 
(70-80 unitslmg) was first dialyzed against 100 mM N- 
ethylmorpholine acetate buffer pH 8.0 (4 x 100 ml) in order to 
remove 2-mercaptoethanol. Subsequently it was mixed with 
spin label in ratios of 1 :1 or 1 :4 in the presence of 10 mM 
glucose and 10 mM Glc-6-P. This mixture was allowed to react 
t o/ I 
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Fig. 1. Deternzinution of K,,lA711,Ui for bruin hexokinuse at low rnetul 
ion concenntrution. Hexokinase activity was monitored at 340 nm on a 
Cary 17D spectrophotometer at  room temperature (21 '.C). The 
concentration of ATP was varied from 2.0 pM to 495 pM. Assay 
solution consisted of 5 mM glucose, 0.5 mM NADP, 1 pg glucose-6- 
phosphate dehydrogenase, 10 mM N-ethylmorpholine acetate, pH 8.0 
and 50 pM MnCl,(a) or 50 pM MgCl,(b). The reaction was started by 
adding 7 pg brain hexokinase. 1 ml assay mixture was used for each 
assay 
at 4 "C for 10 - 12 h. The enzyme was then precipitated twice 
with 70% (NH4),S04 in 100 mM phosphate buffer pH 8.0. 
This resulted in complete removal of Glc-6-P, glucose and 
unreacted spin label. The precipitated enzyme was finally 
dissolved in 100 mM N-ethylmorpholine acetate buffer pH 8.0 
and dialyzed against the same buffer (4 x 100 ml). The spin- 
labeled enzyme had a specific activity of approximately 
60 units/mg protein. For two of the three experiments reported 
in this paper the enzyme had a stoichiometry of spin labeling 
of 1 : l .  In the third experiment the stoichiometry of incor- 
poration of spin label was greater than 1. ESR spectra of 
spin-labeled enzyme were recorded on samples ( "N 30 pl) fill- 
ing glass capillaries using an  E-line (9.5 GHz) Varian ESR 
spectrometer. 
RESULTS 
Kinetic studies with M n ( I I )  
In order to evaluate the effect of replacement of Mg(I1) by 
Mn(II), kinetic studies were carried out in presence of the latter 
ion. Mn(I1) serves effectively as a cofactor and yields about 
50% of the rate found with magnesium. However, K,  values 
for MgATP and MnATP are very similar. In the higher 
concentration range of ATP( > 200 pM), free nucleotide accu- 
mulates, which probably competes with metal-nucleotide on 
the enzyme and brings about the observed inhibition (Fig. 1). 
To clarify the role of Mn(I1) at the direct binding site [2] and 
the metal-nucleotide binding site of hexokinase, kinetic ana- 
lysis of Mn(I1)-activated enzyme was carried out .  Initially the 
kinetics of phosphorylation of glucose were studied under the 
limiting conditions of constant Mn(I1) with variable ATP 
(Fig. 2B) and of constant ATP with variable Mn(l1) (Fig. 2A). 
The reaction velocity has a simple hyperbolic dependence on 
MnATP yielding an apparent Km(MnATP)= 0.03 mM (Fig. 2B), 
which is very similar to KmCMgATP) (see Fig. 1 )  obtained under 
similar conditions. In addition, it also exhibits a hyperbolic 
dependence on [Mn(II)], (Fig. 2A). The activator constant for 
Mn(I1) derived from this is 8.5 pM, which suggests a twofold 
tighter binding of Mn(I1) with E . ATP complex as compared 
to ATP alone [ I l l .  Another important feature of Fig. 2A is 
that in the region of high [Mn(II)],, the plot shows n o  upward 
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Fig. 2. Effect o j '  [MnATP] and [ M n ( I I ) j f  on the initial rates of 
hexokinase reaction. (A) Double-reciprocal plot of velocity versus 
[Mn(II)], at fixed (99 pM) [ATP],. [Mn(I1)lt was varied from 50 pM to 
400 pM. The calculated kinetic parameter KAM,(,,)=8.5 pM. (B) 
Double-reciprocal plot of velocity versus [MnATP]. [Mn(II)], was 
fixed at 50 pM and ATP was varied from 1.5 pM to 29.5 pM. 
Calculated kinetic constant KmMnATP= 30 pM. [Mn(II)], and 
[MnATP] were calculated assuming a metal-nucleotide dissociation 
constant of 15 pM 
or downward curvature. In this range of metal ion concentra- 
tion, the direct Mn(I1) binding site will be approximately 90 % 
saturated. This indicates that binding of Mn(I1) at a direct 
binding site, previously identified by magnetic resonance 
methods, does not have any effect on catalytic activity of the 
enzyme. Activating and inhibitory effects of Mn(I1) on 
hexokinase have been observed albeit at a much higher 
concentration range [2]. 
Substrate activity of /3, y-bidentate Cr(III)ATP for brain 
hexokinase 
Substrate activity of /3, y-bidentate Cr(III)ATP, a sub- 
stitution inert analogue of MnATP, for brain hexokinase 
was assayed by the method of Dunaway-Mariano and Cle- 
land [8]. 1.0 ml 11.6 pM hexokinase was incubated with 
500 pM Mn(II), 1.0 mM Cr(II1)ATP and 1 mM [U-'4C]glucose 
(6.12 x lo6  cpm/mM) in 100 mM N-ethylmorpholine acetate 
buffer pH 6.5 for 10 min at 25 "C. The reaction was stopped by 
precipitating the enzyme and the reaction mixture was ana- 
lyzed as described in Materials and Methods. Fig. 3A shows 
the elution profile from the Dowex column. The amount of 
product, i.e. Glc-6-P . Cr(III)ADP, formed was 13.0 pM, 
indicating that brain hexokinase undergoes a single turnover 
when bidentate Cr(I1I)ATP is used as the substrate in the 
presence of Mn(I1). Similar results were obtained in another 
experiment where Mn(I1) was omitted from the reaction 
mixture (Fig. 3B). It is evident from this experiment that only 
the metal ion interacting with the enzyme via nucleotide is the 
one that participates in catalysis. The direct-binding Mn(I1) 
has no apparent function in this respect. However, its parti- 
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Fig. 3. Assay of substrate acticity o j p ,  y-bidentate Cr(III )ATP.  (A) 
1 .0 ml of the assay mixture contained 11.6 pM brain hexokinase, 
1 mM Cr(III)ATP, 1 mM glucose (6.12 x lo6 cpm/mM) 5 mM 2- 
mercaptoethanol, 100 mM N-ethylmorpholine acetate (pH 6.5) 
and 500pM Mn(I1). The solution was incubated at 25°C for 
10 min, and the product, Cr(III)ADP-Glc-6-P was purified on a 
Dowex-50 x -2H' Column (25 x 0.5 cm). The column was washed 
with 75 ml 10 mM HCI and developed with 75 ml 1 M HCI. 5-ml 
fractions were collected and counted. Radioactivity in the wash 
(caused by unreacted glucose) was too high to be shown in the graph. 
(B) Here the assay mixture contained 7.9 pM enzyme and no Mn(T1). 
The rest of the additions were the samc, as were the subsequent steps of 
the assay 
cipation in some subtle regulatory process cannot be entirely 
ruled out at this stage. 
Determination of Kiapp for f l ,  y-bidentate Cr(III)ATP 
Various isomers of bidentate and tridentate Cr(II1)ATP 
have been found to serve as competitive inhibitors with re- 
spect to MgATP for a number of kinases [8]. Kinetic analysis 
of initial velocity patterns at various concentrations of 
Cr(II1)ATP suggest it to be competitive with respect to 
Mg . ATP for brain hexokinase (Fig. 4). The Dixon-plot 
analysis of these results gave an apparent inhibition constant 
Kiapp= 8 pM. 
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Fig. 4. Determination o] inhibition constant (KJ of Cr(III)ATP 
for bovine brain hexokinase. Standard assay mixture was used with 
ATP concentration 144 pM (-0- ); 288 pM (-- x --) and 432 pM 
(-A -). Various amounts of Cr(1II)ATP were added to the assay 
mixture. Reaction was started by addition of 10 p1 0.6 unit/ml 
hexokinase. 1.0 ml assay mixture was used for each assay. Change 
in absorbance at 340nm was monitored on a Cary-17D spectro- 
photometer at 23 "C. (A) Dixon plot. (B) Replot of slopes of the Dixon 
plot versus I/ATP 
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Fig. 5. PRR titration o.f hexokinuse with A T P  in the presence of MnC1,. 
Solutions contained 50 pM Mn(II), 5 mM 2-mercaptoethanol, 10 mM 
N-ethylmorpholine acetate pH 8.0 and 7.2 - 72.6 pM hexokinase. 
Measurements were made at 9 MHz, 24°C; solid lines are smooth 
curves drawn through the experimental points 
PRR titration with nucleotides 
We have previously shown that brain hexokinase enhances 
the effect of Mn(I1) on the longitudinal relaxation rate of water 
[Mn (El] - 50pM 
7-oc 
70 
Fig. 6. P R R  titration oJ hexokinase with ADP in thepresence ofMnC12. 
Solutions contained 50 pM Mn(II), 5 mM 2-mercaptoethanol, 10 mM 
N-ethylmorpholine acetate pH 8.0 and 39 -274 pM hexokinase. 
Measurements were made at 9 MHz, 24°C. Solid lines are smooth 
curves drawn through the experimental points 
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Fig. 7. P R R  titration of hexokinase with Glc-6-P in the presence of 
Mn(II)  andnucleotide 1igand.s (ATPor ADP).  All solutions contained 
50 pM Mn(II), 5 mM 2-mercaptoethanol, 225 pM hexokinase with 
10 mM N-ethylmorpholine acetate pH 8.0. (B) and (C) contained, in 
addition, 20 pM ATP and 20 pM ADP respectively. E* were measured 
at 9 MHz, 23 "C 
protons [2]. The characteristic enhancement ( E ~ )  for en- 
zyme. Mn(I1) complex, evaluated from PRR enhancement 
measurements, was found to be around 3.5 [2]. However, 
much larger enhancements were observed when nucleotides 
were added to the enzyme. Mn(I1) binary complex. 
In Fig. 5 we see the effect of increasing ATP concentration 
on enhancement behaviour at several fixed enzyme concen- 
trations. Initially, as the nucleotide concentration is increased, 
the observed enhancement, E* increases. At intermediate ATP 
levels, it passes through a broad maximum and then decreases 
gradually at high ATP levels. Initial increase in E* is indicative 
of the formation of an enzyme. ATP . Mn(1I) ternary complex. 
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Table 1. Reverse hcxokinase reaction, i.e. the,formation of glucose and ATP from glucose 6-phosphate and ADP at 22 "C 
Total volume of the sample was 112 pl. It was incubated for 15 min. The reaction was stopped by adding 10 p160 o', perchloric acid. These samples 
were then neutralized with appropriate amount of KOH. Resulting precipitate was removed by centrifugation and supernatant was analyzed on 
thin-layer chromatography using acetone/H,O (90 : 10) solvent system. Specific activity of ['4C]glucose 6-phosphate was 1 O6 cpm/pmole 
Serial no. Buffer Sample composition Glucose 
formed ~~~ ~ ~~ 
enzyme Mn(I1) ADP [14C]Glc-6-P 
mM PM 
~ ~~ 
PM 
1 0 3 M NEMA 102 6 4 46 3 57 69 6 I 0  
2 0 1 M Bistris 86 2 4 46 3 57 69 6 10 4 
pH 8 0 
pH 6 0  
Table 2. Comparison qf MnjII) concentrationsmeasuredby ESR in the presence ofvarious amounts of enzyme and Cr(III)ATP with the calculated 
values from Scheme I and Scheme II 
The samples contained 10 mM N-ethylmorpholine acetate, pH 8.0, 5 mM 2-mercaptoethanol and appropriate amounts of enzyme, Mn(1I) and 
Cr( I I1)ATP. 2 0 4  samples were placed in glass capillaries and Mn(I1) ESR spectra were recorded on an E-line Varian spectrometer. Instrumental 
settings were 0.25 s time constant, 12.5 G modulation amplitude, 100 kHz modulation frequency, 12 mW microwave power, 9.5 GHz 
microwave frequency and 8 min scan time. All the samples were monitored at 22 "C. Various dissociation constants used to calculate [Mn], are E 
+ M G E M ,  K,=25*4 pM [2j; E+Cr(III)ATP~E.Cr(III)ATP,  Ki,,,=8 p M ;  Cr(II1) ATP+Mn(II)GCr(III)ATP Mn; K,=43+19 pM 
(determined by an independent experiment using ESR) and E . M + Cr(II1)ATPGE. M . Cr(I1I)ATP; Kiapp = 8 pM 
observed" calculatedb 
Scheme I1 Scheme I 
1 
2 
3 
82.3 
78.8 
72.8 
43.5 87.0 35.1 36.5 i 1.9 41.8 1.8 
83.3 83.3 28.3 31.4 k 2.8 39.1 k2.9 
154.8 76.9 23.3 20.8 k3.7 28.2+ 3.5 
a Reproducibility of Mn(I1) measurement for a given sample was within 5%.  
Errors presented here reflect the errors in the determination of K,(E. M) and K,[Cr(III)ATP. Mnj. 
The decrease in E* at high ATP concentrations reflects the 
competition between the free nucleotide and the metal- 
ion . nucleotide complex for binding at the nucleotide site 
on the enzyme. Similar results were obtained when en- 
zyme.Mn(I1) was titrated with ADP (Fig. 6). Brain hexo- 
kinase thus binds Mn(I1) through the nucleotide bridge, a 
coordination scheme characteristic of several kinase ternary 
complexes [4]. 
Ejfect of Glc-6-P on PRR enhancement of various enzyme 
complexes 
E .  Mn. Addition of Glc-6-P to E .  Mn complex does not 
alter the PRR characteristics of the binary complex (Fig. 7A). 
However, under our experimental conditions Glc-6-P is 
known to interact with E .  Mn complex [2]. 
E .  A TP . Mn. Addition of small amounts of ATP to E . Mn 
results in a large increase in observed enhancement. A solution 
containing hexokinase (225 pM), Mn(I1) (50 pM) and ATP 
(20 pM), when titrated with Glc-6-P, resulted in gradual 
decrease in observed enhancement (Fig. 7B). On extrapolation 
to infinite Glc-6-P concentration, the E* approaches a value 
close to that of E . Mn . Glc-6-P. This decrease in observed 
enhancement on addition of Glc-6-P to ternary E . ATP . Mn 
complex is attributed to the competitive displacement of 
ATPMn by Glc-6-P from the enzyme. This interpreation is 
also consistent with earlier kinetic studies [12]. 
E.ADP.Mn. Addition of the product Glc-6-P to the 
ternary hexokinase . ADP . Mn complex also results in a de- 
crease in PRR enhancement (Fig. 7C). The observed decrease 
in PRR enhancement may arise as a result of displacement of 
ADP by Glc-6-P for which no kinetic evidence exists. 
Alternatively, since ADP . Mn and Glc-6-P are the products 
of the hexokinase reaction, there may be a formation of 
E . ADP . Mn. Glc-6-P quaternary complex, which has low 
characteristic enhancement. In case the latter possibility is 
true, there will be formation of glucose and ATP because of 
the reverse reaction. The amount produced will depend upon 
the equilibrium constant between E . ADP . Mn. Glc-6-P and 
E . ATP . Mn . glucose. In an attempt to detect the formation of 
ATP and glucose in a mixture of enzyme, ADP, Mn(I1) 
and Glc-6-P, we used [U-'4C]Glc-6-P. Formation of glu- 
cose could be detected (Table 1). However, the data indi- 
cate that most of the nucleotide will be present as 
E . ADP . Mn . Glc-6-P complex. These results strongly sup- 
port the suggestion that the observed decrease in PRR 
enhancement is predominantly due to the formation of a 
quaternary complex, E . ADP . Mn . Glc-6-P. 
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1 
+Cr ( IILjATP 
Interaction o j  p, y-bidentate Cr(III)ATP with 
hexokinase . Mn(II )  
To establish whether a complex of the form hexo- 
kinase . Mn . Cr(II1)ATP containing two cations could be 
formed, binding of Mn(I1) with the enzyme was studied in the 
presence of Cr(I1I)ATP. Under these conditions the nucleotide 
site is blocked by the non-dissociable Cr(II1) ion. At different 
4 
+Cr( I I I l  ATP 
+ M  
E, E.M E 
/I_ +2.M 
E. Cr(JE1 ATP 
Scheme - I Scheme - II 
concentrations of the enzyme, Mn(I1) and Cr(III)ATP, free 
Mn(I1) concentration was determined using ESR (Table 2). 
These results were analysed assuming either the formation of 
E . Mn . Cr(1II)ATP or E . Cr(1II)ATP complex (Schemes I 
and 11). Various coupled equilibria involved were solved using 
a computer program [13]. The calculated values of [Mn(II)],, 
according to Schemes I and 11, along with measured values, are 
presented in Table 2. This analysis was carried out assuming 
neither co-operativity nor anti-cooperativity between the 
metal binding site and the nucleotide binding site, i.e. the 
binding of Mn(I1) to enzyme does not affect the affinity of 
nucleotide . metal-ion for the enzyme. This assumption is 
supported by the fact that in kinetic studies no curvature was 
observed in double-reciprocal plots (Fig. 2A). A good agree- 
ment between the [Mn(II)lf, calculated according to Scheme I, 
and the measured values suggests that Mn(I1) binds to 
hexokinase at a tight binding site even when the nucleotide 
binding site is occupied by Cr(1II)ATP. 
A 
I 
I I I I I 1 . I  I I I I 1 I I  I I I  I I I I  I I  I I I I I I I I I I I I  I I 1 I I 1 I I 1 1 * . 1 , 1  I * I r I r I I I I  
3360 5370 3380 3390 3400 3410 3420 
Gauss 
Fig 8 ESR Jpectra ( A )  10 pMfree p i n  lubelund ( B )  140 pM spin-labrledhexokinasr, both in I00 mM N-ethylnzorphohne utetute buffer, p H  8 0, 
19 c 
Table 3. Ejfict of Mni l I )  tind . 4TPMn on thr height o f ' the  central ESR  line o f t h e  hexokinuse bound spin label 
ESR recording conditions were: scan range, I00C; receiver gain, 3.2 x lo4; Field set, 3390G; scan timc. 8 min; modulation frequency, 
100 kHz; temperature 19+ 1 "2; microwave frequency, 9.5 GHz. In addition to the above conditions: time constant=0.25 min (serial no. I), 
0.5 min (2,3); modulation amplitude=2.0 G (I) ,  4.0 G (2.3); microwave power=20mW (l) ,  12 mW (2,3) 
Serial no Concentration of spin-labeled 
enzyme 
CIM 
Signal height of the central ESR line in the presence of hgdnds 
no addition Mn(l1) ATP Mn(I1) 
~~~~~~ ~~ _ _  ~ ~~~ ~~ 
I 
7 - 
66 
44 
48 
20.5 
30 
39 
15.00 
( L O 0  pM h, 
14 
(100 pM') 
23.5 
(100 pMh) 
18 
(250pM"; 200pM') 
21 
(500pM'; 500pM') 
36 
,600 pMc ; 500 pM ') 
' Stoichiometry o f  incorporation of spin label by enzymc in this sample was greater than 1. In the other two experiments the stoichiometry of 
spin labeling was 1 : I .  
Numbers in parentheses represent total concentration of Mn(I1). 
Numbers in  parentheses represent total concentration of ATP. ' 
67.5 
Interaction of‘ Mn( I I )  and MnATP with spin-labeled enzyme solvent water molecules as successive binding sites are occu- 
Fig. 8B shows the ESR spectrum of the spin-labeled 
enzyme, which had a stoichiometry of spin labeling of 1 : 1. The 
shape of the ESR spectrum is characteristic of moderately 
immobilized label, with spectral lines broadened and much 
reduced in height. Binding of Mn(I1) leads to a reduction in the 
amplitude of the central ESR spectral line without any 
appreciable broadening [14]. However, binding of ATPMn 
{prepared under conditions where there is no free Mn(I1) 
present 1. e. [ATP] > [Mn(II)] and [ATPMn] 2 K,(ATPMn)} 
does not have any significant effect on the resonance line 
amplitude (Table 3). The reduction in signal height arises as a 
result of dipolar interaction between the two electron spins, 
i.e. the Mn(I1) and the nitroxyl spin label, on the same 
macromolecule [I 51. This observation would indicate that the 
ATPMn binding site on the enzyme is at  a locus different from 
the direct Mn(I1) binding site on the enzyme. 
DISCUSSION 
The data presented in Fig. 1 and 2 show that Mn(I1) can 
replace Mg(1I) as a cofactor for the hexokinase reaction. This 
replacement, however, reduces the activity of the enzyme by 
about SOo/; though the affinity of the enzyme for ATPMn 
remains the same as for ATPMg. The large PRR enhancement 
observed in the presence of nucleotide (ATP or ADP), 
compared to that produced by the enzyme. manganese sys- 
tem, places brain hexokinase in the category of creatine kinase 
[4] arginine kinase [I61 and phosphofructokinase [17]. En- 
hancement pattern alone suggests that ATPMn/ADPMn 
binds to the enzyme to form a ternary complex via a substrate 
bridge. Binding of ATP(ADP) to enzyme in the absence of 
metal ion [I81 suggests a direct interaction of nucleotide with 
the enzyme, which in turn supports the idea of a substrate- 
bridge ternary complex. Enzyme bridge or metal bridge 
schemes for the ternary complex are very unlikely on the basis 
of enhancement data. However, the results do  not preclude 
some kind of Mn(I1). enzyme interaction once the metal ion is 
bound to the nucleotide, giving a complex of the type E 1 
[16,17]. This possibility also finds support from the fact that 
binding affinity of the enzyme for ATPMg is higher than for 
free ATP [19]. But the fact that Cr(1II)ATP binds at  the 
ATPMn site and serves as a substrate for hexokinase, rules out 
the possibility of interaction of nucleotide-bound metal ion 
with the enzyme (E 1 ), as such an interaction is unlikely 
between the Cr(1II) atom and the enzyme since Cr(1II)ATP 
exchanges ligands very slowly. 
Displacement of ATPMn from the enzyme by Glc-6-P is 
consistent with earlier kinetic studies [20] and supports the 
view that the g-phosphoryl group of ATP and the phosphoryl 
group of Glc-6-P interact at the same subsite on the enzyme 
[ 18,20,21]. Addition of Glc-6-P to enzyme. ADP . Mn also 
causes a decrease in enhancement (Fig. 7C) similar to that 
observed when Glc-6-P is added to enzyme ’ ATP . Mn 
(Fig. 7B). However, in view of the observed reverse reaction 
(Table 1 ), this decrease has been attributed to the formation of 
a quaternary complex. Decrease in PRR enhancement in the 
quaternary complex, as compared to the ternary complex, 
implies that the active site becomes less and less accessible to 
/s 
‘M 
/s  
‘M 
pied [22,23]. 
Hexokinase is somewhat unusual among kinases in that it 
forms a tight E . Mn binary complex. Possibility of binding of 
two metal ions in the presence of ATP(ADP) is indicated by 
the displacement of ATPMn from the enzyme by Glc-6-P, 
resulting in the formation of E . Mn . Glc-6-P. Further, sup- 
port for the formation of a bimetallic complex, in which one 
metal ion is directly bound to the enzyme and another co- 
ordinated to phosphoryl groups of ATP, comes from the fact 
that Mn(I1) can interact with E . Cr(II1)ATP complex. The 
two metal binding sites appear to be of a non-interactive 
type. A similar conclusion has been drawn from our studies on 
the spin-labeled enzyme. We have observed that binding of 
Mn(I1) to enzyme reduces the intensity of the ESR signal of 
the covalently linked nitroxyl radical. However, binding of 
ATPMn (where ATP > Mn(II)>enzyme) docs not have any 
significant effect on ESR signal intensity. This again supports 
the idea that the two metal ions interact at two spatially 
different sites on the enzyme surface. 
Various isomers of Cr(II1)ATP have proved to be very 
useful in probing the active conformers of nucleotide . Mn(II), 
which serve as a substrate for various kinases [24]. The 
preparation of Cr(III)ATP, used in our experiments, is a 
racemic mixture of various isomers of bidentate Cr(II1)ATP. 
Possibility of presence of small amounts of tridentate 
Cr(II1)ATP in this preparation cannot be ruled out. At this 
stage no attempt was made to further resolve the various 
isomers of bidentate Cr(II1)ATP. As in the case of yeast 
hexokinase [S] and other mammalian hexokinases [25], it acts 
as a substrate for brain hexokinase (type 1) and the product 
Cr(I1I)ADP. Glc-6-P is released slowly. This observation 
clearly suggests that the metal ion interacting via nucleotide 
substrate is the only one required for catalysis. The second 
metal ion, binding directly to the enzyme [2], does not appear 
to play any role in enzyme activity. However, the metal ion at 
this site can be used as a paramagnetic reference point to map 
the sugar binding sites. Studies in this direction are currently 
under way in our laboratory. 
G.K.J.  and S.R.K. would like to acknowledge the constant 
encouragement provided by Professor R. Vijayaraghavan during the 
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